The MIND diet was associated with slower cognitive decline in both Black and white older adults, but relationships appeared ...

GAD Parkinson’s disease gene therapy has met its primary endpoint. The sham-controlled bridging study evaluated the company's ...

According to MeiraGTx, AAV-GAD is designed to reprogramme dysfunctional circuits in the Parkinson's brain through the local ...

MeiraGTx is looking to march its Parkinson’s disease treatment forward into phase 3 after the gene therapy improved motor ...

A MeiraGTx Holdings gene therapy for Parkinson’s disease has preliminary data from a small clinical trial showing the one-time treatment showed both safety and efficacy, results that lay the ...

Gregory and Deborah Macres from California lost their son, Gregory, in 1997, when he was just 4 years old. Little Gregory had ...

The incubator is designed to draw cell and gene therapy researchers and drugmakers to work at the hub, where they can develop ...

Advancements in organoid technology are crucial for Parkinson's disease research, providing human-relevant models for ...

Researchers have developed a revolutionary magnetogenetics technology that can control brain circuits non-invasively using ...

A new technology enables the control of specific brain circuits non-invasively with magnetic fields, according to a preclinical study. The technology holds promise as a powerful tool for studying the ...

Related Robot finger might someday take your pulse, check for tumors Report gives update on boys with rare brain disease 6 ...

A Phase I/II trial (NCT05603312) with MeiraGTx's AAV-GAD Parkinson’s disease gene therapy has met its primary endpoint. The sham-controlled bridging study evaluated the company's AAV-GAD therapy ...